KS
Katie Sunnucks
Founder of Vantage Biosciences
United Kingdom
Overview
Katie Sunnucks is a Biotech VC at ALSA Ventures in the UK, with a background that includes roles such as Investment Associate and Co-Founder at Vantage Biosciences. She holds a Master of Philosophy from the University of Cambridge and has experience in various areas including business strategy, market access, and venture capital.
Katie Sunnucks has excelled in her career by co-founding Vantage Biosciences and working as an Investment Associate at ALSA Ventures, demonstrating her expertise in the biotech industry and venture capital. Her educational background includes a Master of Philosophy from the University of Cambridge, showcasing her commitment to academic excellence in the field.
Work Experience
Investment Associate
2021 - Current
Investment Analyst
2019 - 2021
ALSA Ventures is a London based international life science investor focused on novel therapeutics.
Co-Founder
2023
Director Of Operations
2021 - 2024
Promatix is a data driven company that uses multi-omic information to develop the next generation of cancer therapeutics
Life Sciences Investment Intern, Venture Capital
2019 - 2019
Account Manager
2016 - 2018
Health Economics and Market Access Research Assistant
2015 - 2016
Johnson & Johnson is a healthcare provider, expertise in innovative medicine and MedTech for every patient & for everyone.
Research Scholar
2014 - 2014
Received a research and international scholarship to work in the Department of Microbiology at WUSTL, where I established blood type from saliva samples using lab techniques such as gel electrophoresis and PCR.